We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$894M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
51
Cisco
CSCO
$457B
$51.7M 0.32%
2,081,992
+87,086
+4% +$2.08M
WELL icon
52
Welltower
WELL
$169B
$50M 0.31%
797,144
+19,596
+3% +$1.23M
UPS icon
53
United Parcel Service
UPS
$88.6B
$48.4M 0.3%
471,796
+6,561
+1% +$659K
UNP icon
54
Union Pacific
UNP
$174B
$47.9M 0.3%
480,029
+42,081
+10% +$4.08M
VOD icon
55
Vodafone
VOD
$36.3B
$47.9M 0.3%
1,433,820
+179,931
+14% +$6.37M
HD icon
56
Home Depot
HD
$331B
$47M 0.29%
580,315
+61,468
+12% +$4.85M
FLRN icon
57
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.09B
$44.4M 0.27%
1,448,312
+59,401
+4% +$1.82M
ABBV icon
58
AbbVie
ABBV
$443B
$43.2M 0.27%
765,394
+42,929
+6% +$2.25M
EMB icon
59
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$42.7M 0.26%
370,025
+18,994
+5% +$2.16M
V icon
60
Visa
V
$684B
$41.8M 0.26%
793,804
+60,716
+8% +$3.17M
PNC icon
61
PNC Financial Services
PNC
$99.7B
$41.8M 0.26%
468,872
+47,594
+11% +$4.06M
LMT icon
62
Lockheed Martin
LMT
$134B
$41.1M 0.25%
255,652
-7,973
-3% -$1.3M
BMY icon
63
Bristol-Myers Squibb
BMY
$133B
$41.1M 0.25%
847,035
-704
-0.1% -$34.7K
PPL
64
PPL Corp
PPL
$26.5B
$40.9M 0.25%
1,237,328
+103,390
+9% +$3.26M
UNH icon
65
UnitedHealth
UNH
$376B
$40.2M 0.25%
492,178
+38,512
+8% +$3.03M
GILD icon
66
Gilead Sciences
GILD
$162B
$40.1M 0.25%
483,640
+175,487
+57% +$13.7M
ADT
67
DELISTED
ADT Corp
ADT
$40M 0.25%
1,143,988
+239,845
+27% +$7.69M
CME icon
68
CME Group
CME
$96.3B
$39.6M 0.24%
558,387
-16,608
-3% -$1.17M
LNCO
69
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$38.8M 0.24%
1,241,154
+218,196
+21% +$6.17M
RDS.A
70
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$38.4M 0.24%
466,424
+52,117
+13% +$4.07M
NVS icon
71
Novartis
NVS
$297B
$38.4M 0.24%
473,467
+51,130
+12% +$4.02M
ET icon
72
Energy Transfer Partners
ET
$70.1B
$37.7M 0.23%
1,278,450
+40,656
+3% +$1.03M
META icon
73
Meta Platforms (Facebook)
META
$1.42T
$37.2M 0.23%
553,124
+118,929
+27% +$7.32M
D icon
74
Dominion Energy
D
$60.8B
$36.9M 0.23%
516,270
+27,489
+6% +$1.93M
RDS.B
75
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$36.9M 0.23%
423,843
+27,522
+7% +$2.29M

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $894M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.